BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 17115107)

  • 1. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of contralateral breast cancer.
    Chen Y; Thompson W; Semenciw R; Mao Y
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):855-61. PubMed ID: 10548312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral breast cancer.
    Gogas J; Markopoulos C; Skandalakis P; Gogas H
    Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk.
    Hemminki K; Ji J; Försti A
    Cancer Res; 2007 Feb; 67(3):868-70. PubMed ID: 17283115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.
    Rawal R; Lorenzo Bermejo J; Hemminki K
    Br J Cancer; 2005 Jan; 92(1):162-6. PubMed ID: 15570309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral breast cancer: factors associated with stage and size at presentation.
    Mertens WC; Hilbert V; Makari-Judson G
    Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
    Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
    Brandt A; Lorenzo Bermejo J; Sundquist J; Hemminki K
    Breast Cancer Res Treat; 2010 May; 121(1):133-41. PubMed ID: 19641988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.